Balchem Net Margin
The Net Profit Margin of Balchem (BCPC) as of Jul 21, 2026 is 14.93 %. In the previous year, Net Profit Margin was 13.47 % — a change of 10.82% (higher).
Get this data via API
Financial Data API
Net Margin
14.93 %
YoY
10.82%
Last updated:
Net Profit Margin of Balchem is 2026 14.93 % . Net Profit Margin of Balchem was 2025 13.47 % . It decreases by 10.82% higher compared to the previous year.
For Balchem, the net margin of 14.9% is up versus 12.0% a few years ago.
Access this data via the Eulerpool API
Balchem Stock analysis
What does Balchem do? Balchem Corp is a US-based company specialized in the manufacture and sale of chemical additives and ingredients for a variety of industries. The company was founded in 1967 and is headquartered in New York.
Balchem Corp offers a wide range of products and services, divided into different divisions. The largest divisions are Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. In the Human Nutrition & Health division, Balchem produces ingredients for use in functional foods, supplements, beverages, and other health products. The Animal Nutrition & Health division manufactures animal feed additives aimed at improving the health and growth of livestock.
The Specialty Products division produces specialty chemicals for a variety of applications. Balchem Corp is also specialized in the development of fragrances and flavors. Balchem has become one of the leading manufacturers of amino acid derivatives, providing high-quality solutions for veterinary applications.
Balchem Corp's history is characterized by expansion and diversification. In its early years, the company focused on the manufacture of chemical additives for the agriculture industry. One of Balchem's first achievements was the development of an additive that prevents feed from molding during transportation and storage. Over the years, Balchem has continuously expanded its offerings and now has a broad product portfolio serving many different industries.
Balchem's expansion continued in the 1990s when the company started to expand its business into the human nutrition sector. Today, the Human Nutrition & Health division is the company's fastest-growing segment. Similar to the animal nutrition industry, Balchem also offers a variety of ingredients in this sector that have higher nutrient density and/or better bioavailability than conventional foods.
In recent years, Balchem Corp has shown strong growth dynamics. In 2019, the company had a revenue of nearly $650 million. The company has been listed on NASDAQ since 1997 and has continuously increased its market value in recent years.
Overall, Balchem Corp is an innovative and diversified company specialized in the manufacture of chemical additives and ingredients for various industries. The company has shown strong growth dynamics over the years and has continuously expanded its portfolio to meet the changing needs of its customers. With its broad product lines divided into different divisions, Balchem has solidified its position as a leading provider of additives and ingredients in many industries.
Balchem Corp is a US-based company specialized in the manufacture and sale of chemical additives and ingredients for a variety of industries. Balchem is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Balchem stock
Net Profit Margin of Balchem is 14.93 % in 2026.
Access this data via the Eulerpool API
Margins — Balchem
All Key Metrics — Balchem
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth